Boehringer ingelheim and cognizant announce the launch of a unified cloud platform to bring innovative therapies to patients faster

Powered by the veeva development cloud, the system brings together previously disparate functions to streamline the medicinal development process and enhance operational efficiencies teaneck, n.j. , march 11, 2025 /prnewswire/ -- cognizant (nasdaq: ctsh) and boehringer ingelheim  announced today the go-live of an end-to-end technology platform powered by the veeva development cloud, designed to accelerate the global biopharmaceutical leader's delivery of life-transforming treatments.
CTSH Ratings Summary
CTSH Quant Ranking